04Aug 2022
Better preservation of erectile function in localized prostate cancer patients with modern proton therapy: Is it cost‐effective?

Better preservation of erectile function in localized prostate cancer patients with modern proton therapy: Is it cost‐effective?

Stereotactic body radiation therapy (SBRT) has gradually been recognized as favorable curative treatment for localized prostate cancer (PC). However, the high rate of erectile dysfunction (ED) after traditional photon‐based SBRT remains an ongoing challenge that greatly impacts the quality of life of PC survivors. Modern proton therapy allows higher conformal SBRT delivery and has the potential to reduce ED occurrence but its cost‐effectiveness remains uninvestigated. Upon assumption‐based modeling, the results of current study support the use of proton SBRT in younger localized PC patients who are previously potent, for better preservation of erectile function.

  • #urology

Like

Save

Share